KRAS and lung adenocarcinoma: Notably, the comparable frequency of KRAS G12C mutations in the “large cell carcinoma” histology group and lung adenocarcinoma supports the hypothesis that a substantial portion of large cell carcinomas are undifferentiated TTF1-negative adenocarcinomas.